Brookstone Capital Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
Brookstone Capital Management's AGL Position: Q1 2026 in Review
Brookstone Capital Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 489 shares — an estimated $8.42K sold.
Brookstone Capital Management first reported a position in AGL in Q4 2025 and held it in 1 quarter. The position peaked at $8.42K in Q4 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.
- Brookstone Capital Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
- Brookstone Capital Management sold 489 Agilon Health shares in Q1 2026, an estimated $8.42K.
- Brookstone Capital Management first reported a position in Agilon Health in Q4 2025 and held it in 1 quarter.
- Brookstone Capital Management's Agilon Health position peaked at $8.42K in Q4 2025.
- 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.
Based on Brookstone Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.